Lipoprotein-associated phospholipase A(2) activity and mass in relation to vascular disease and nonvascular mortality

Lipoprotein-associated phospholipase A(2) activity and mass in relation to vascular disease and nonvascular mortality

Detalles Bibliográficos
Main Authors:	Parish, S, Offer, A, Thompson, A, Link, E, Di Angelantonio, E, Bowman, L, Armitage, J, Danesh, J, Collins, R, Collaborati, H
Formato:	Journal article
Publicado:	2010

Títulos similares

Lipoprotein-associated phospholipase A₂ activity and mass in relation to vascular disease and nonvascular mortality.
por: Heart Protection Study Collaborative Group
Publicado: (2010)

Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.
por: Erqou, S, et al.
Publicado: (2009)

The effects of vascular and nonvascular adverse events and of extended-release niacin with laropiprant on health and healthcare costs
por: Kent, S, et al.
Publicado: (2016)

Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies.
por: Thompson, A, et al.
Publicado: (2010)

Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection Study.
por: Parish, S, et al.
Publicado: (2012)

N-terminal pro-B-type natriuretic peptide and vascular disease among 20,536 patients in the MRC/BHF heart protection study
por: Emberson, J, et al.
Publicado: (2005)

No Impact of KIF6 Genotype on Vascular Risk or Statin Benefit in the Heart Protection Study
por: Hopewell, J, et al.
Publicado: (2009)

Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.
por: Danesh, J, et al.
Publicado: (2005)

Economic analysis of simvastatin in 20,536 people at different levels of vascular disease risk based on US costs: Randomised placebo-controlled trial
por: Mihaylova, B, et al.
Publicado: (2005)

Cystatin C and risk of vascular and nonvascular mortality: a prospective cohort study of older men.
por: Emberson, JR, et al.
Publicado: (2010)

Associations of toothbrushing behaviour with risks of vascular and nonvascular diseases in Chinese adults
por: Zhuang, Z, et al.
Publicado: (2021)

Comparison of the outcomes of vascularized and nonvascularized bone grafting in treatment of scaphoid nonunion
por: Ali Tabrizi, et al.
Publicado: (2022-01-01)

Association of CETP gene variants with risk for vascular and nonvascular diseases among Chinese adults
por: Millwood, I, et al.
Publicado: (2017)

MRC/BHF heart protection study (HPS): Mortality, cancer incidence and major vascular events during 4 years post-trial follow-up of HPS
por: Bulbulia, R, et al.
Publicado: (2007)

Lipoprotein-associated phospholipase A2 loss-of-function variant and risk of vascular diseases in 90,000 Chinese adults
por: Millwood, IY, et al.
Publicado: (2016)

Lipoprotein(a) genetic variants associated with coronary and peripheral vascular disease but not with stroke risk in the Heart Protection Study.
por: Hopewell, J, et al.
Publicado: (2011)

C-reactive protein in the Heart Protection Study Reply
por: Emberson, J, et al.
Publicado: (2011)

Multiple Buttress Reconstruction for Extended Total Maxillectomy by Mixed Use of Vascularized and Nonvascularized Fibula
por: Itaru Tsuge, MD, PhD, et al.
Publicado: (2024-06-01)

MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial
por: Collins, R, et al.
Publicado: (2002)

Lipoprotein-Associated Phospholipase A2 Activity as Potential Biomarker of Vascular Dementia
por: Giovanni Zuliani, et al.
Publicado: (2023-02-01)

Lipoprotein-associated phospholipase A2, vascular inflammation and cardiovascular risk prediction
por: Krishnankutty Sudhir
Publicado: (2006-06-01)

Pitfalls in Ultrasound Diagnosis of Vascular Malformations: A Retrospective Review of 14 Nonvascular Tumors Treated as Vascular Malformations
por: Shintaro Mitamura, et al.
Publicado: (2025-02-01)

Cohort profile: the BangladEsh Longitudinal Investigation of Emerging Vascular and nonvascular Events (BELIEVE) cohort study
por: Anisur Rahman, et al.
Publicado: (2025-01-01)

Simultaneous Reconstruction of the Bilateral Maxillae and Nasal Hard Structure Using a Vascularized and Nonvascularized Fibula
por: Itaru Tsuge, MD, PhD, et al.
Publicado: (2024-06-01)

Impact of apolipoprotein(a) isoform size on lipoprotein(a) lowering in the HPS2-THRIVE study
por: Parish, S, et al.
Publicado: (2018)

Nonvascular retinal imaging markers of preclinical Alzheimer's disease
por: Peter J. Snyder, et al.
Publicado: (2016-01-01)

Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study.
por: Hopewell, J, et al.
Publicado: (2013)

Body-mass index and all-cause mortality - Authors' reply
por: Di Angelantonio, E, et al.
Publicado: (2017)

Economic evaluation of the Heart Protection Study
por: Briggs, A, et al.
Publicado: (2003)

A Case of Solitary Nonvascularized Corneal Epithelial Dysplasia
por: Tomoya Morii, et al.
Publicado: (2016-01-01)

The Fate of Nonvascularized Fat Grafts: Histological and Bioluminescent Study
por: Ataru Sunaga, MD, et al.
Publicado: (2013-09-01)

Body-mass index, abdominal adiposity, and cardiovascular risk Reply
por: Wormser, D, et al.
Publicado: (2011)

N-BNP and vascular disease among 20,536 patients in the MRC/BHF Heart Protection Study
por: Emberson, J, et al.
Publicado: (2005)

The survival condition and immunoregulatory function of adipose stromal vascular fraction (SVF) in the early stage of nonvascularized adipose transplantation.
por: Ziqing Dong, et al.
Publicado: (2013-01-01)

Biomarkers of inflammation predict both vascular and non-vascular mortality in older men.
por: Clarke, R, et al.
Publicado: (2008)

Biomarkers of inflammation predict both vascular and non-vascular mortality in older men
por: Clarke, R, et al.
Publicado: (2008)

A simple assay for a human serum phospholipase A2 that is associated with high-density lipoproteins
por: Nenad Petrovic, et al.
Publicado: (2001-10-01)

Dynamics of dense electronegative low density lipoproteins and their preferential association with lipoprotein phospholipase A2
por: John W. Gaubatz, et al.
Publicado: (2007-02-01)

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
por: Kaptoge, S, et al.
Publicado: (2010)

Lipoprotein-Associated Phospholipase A2 Mass Level Is Increased in Elderly Subjects with Type 2 Diabetes Mellitus
por: J. Fortunato, et al.
Publicado: (2014-01-01)